Gene · 389421
NIH grants1,664
NIH grants whose papers are about the gene, through NIH's grant-paper links.
381 to 400 of 1,664
Download this page as JSON| Grant | Title | LIN28B papers | Newest fiscal year |
|---|---|---|---|
| R01DK125015 | Endothelial miR-17~92 protects against acute kidney injury | 2 | 2023 |
| R01DK125097 | Mapping human hematopoietic stem cell development | 2 | 2023 |
| R01GM135599 | Structural and functional studies of chromatin modifiers | 2 | 2023 |
| R01MH121394 | Integrative approaches to identification and interpretation of genes underlying psychiatric disorders | 2 | 2023 |
| R01NS055925 | Splicing Regulation of Spinal Muscular Atrophy Genes | 2 | 2023 |
| T32GM007739 | Weill Cornell/Rockefeller/Sloan Kettering MST Program | 2 | 2023 |
| T32GM008216 | Predoctoral Training Program in Genetics | 2 | 2023 |
| F30CA236031 | Augmenting Pancreatic Cancer Immunotherapy via TGFβ Pathway Inhibition | 1 | 2023 |
| F31CA265285 | Regional selectivity of oncohistone H3K27M on glial development and glioma pathogenesis | 1 | 2023 |
| F31MH124282 | Using microRNA-target chimeras to study post-transcriptional gene regulation in the mammalian CNS | 1 | 2023 |
| I01BX004446 | Molecular Mechanisms of a Male-Specific Positive Feedback Loop in Liver Cancer | 1 | 2023 |
| K12HD051959 | Hormones and Genes in Women's Health: From Bench to Bedside | 1 | 2023 |
| P01AI035296 | Mechanisms of peripheral induction of T-cell tolerance | 1 | 2023 |
| P20GM103636 | Expanding Excellence in Developmental Biology in Oklahoma Supplement: 3D Human Lung Tissue Model to Dissect Cellular Responses upon SARS-CoV-2 Infection | 1 | 2023 |
| P41GM109824 | National Center for Dynamic Interactome Research | 1 | 2023 |
| R01CA122959 | CCAR2 as a Target for Prevention of Colorectal Cancer. | 1 | 2023 |
| R01CA138264 | Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer | 1 | 2023 |
| R01CA218026 | The Function of EGFL6 in Ovarian Cancer Cell Biology, Tumor Initiation, and Therapy | 1 | 2023 |
| R01CA222959 | Mechanism of Intratumoral Transport of Particulate Drugs | 1 | 2023 |
| R01CA226875 | Myeloid reprogramming in response to acute radiation tissue damage | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/grants?page=20